Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium phosphosilicate (CPS) putty is a synthetic, resorbable, alloplastic bone graft substitute primarily used in dental and orthopedic surgery. Composed of bioactive glass-ceramic particles (calcium phosphosilicate) in a synthetic carrier, it acts as an osteoconductive scaffold that promotes the regeneration of new bone. Upon implantation, the material undergoes a series of surface reactions leading to the formation of a hydroxycarbonate apatite (HCA) layer, which facilitates the attachment and proliferation of osteoblasts. It is commonly employed in socket preservation, ridge augmentation, and sinus lifts to prevent alveolar bone resorption following tooth extraction. In clinical trial contexts, it is often used as a positive control for evaluating new regenerative materials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium phosphosilicate.